Connection

David Priest to Humans

This is a "connection" page, showing publications David Priest has written about Humans.
Connection Strength

0.095
  1. Fluorescence fluctuation spectroscopy: an invaluable microscopy tool for uncovering the biophysical rules for navigating the nuclear landscape. Biochem Soc Trans. 2019 08 30; 47(4):1117-1129.
    View in: PubMed
    Score: 0.025
  2. Nascent mutant Huntingtin exon 1 chains do not stall on ribosomes during translation but aggregates do recruit machinery involved in ribosome quality control and RNA. PLoS One. 2020; 15(7):e0233583.
    View in: PubMed
    Score: 0.007
  3. Accumulation of plasma reduced folates after folic acid administration. Semin Oncol. 1999 Apr; 26(2 Suppl 6):38-41.
    View in: PubMed
    Score: 0.006
  4. Effects of antisense-based folypoly-gamma-glutamate synthetase down-regulation on reduced folates and cellular proliferation in CCRF-CEM cells. Biochem Pharmacol. 1998 Jun 15; 55(12):2031-7.
    View in: PubMed
    Score: 0.006
  5. Evidence for involvement of tyrosine phosphorylation in taxol-induced apoptosis in a human ovarian tumor cell line. Biochem Pharmacol. 1994 Sep 15; 48(6):1265-72.
    View in: PubMed
    Score: 0.005
  6. Disposition of folic acid and its metabolites: a comparison with leucovorin. Clin Pharmacol Ther. 1994 May; 55(5):501-8.
    View in: PubMed
    Score: 0.004
  7. Leucovorin as a prodrug. Adv Exp Med Biol. 1993; 339:31-40; discussion 41-2.
    View in: PubMed
    Score: 0.004
  8. Folate metabolites as modulators of antitumor drug activity. Adv Exp Med Biol. 1993; 338:693-8.
    View in: PubMed
    Score: 0.004
  9. Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously. J Natl Cancer Inst. 1991 Dec 18; 83(24):1806-12.
    View in: PubMed
    Score: 0.004
  10. A sensitive radioenzymatic assay for (S)-5-formyltetrahydrofolate. Anal Biochem. 1991 Aug 01; 196(2):284-9.
    View in: PubMed
    Score: 0.004
  11. Human red blood cell-mediated metabolism of leucovorin [(R,S)5-formyltetrahydrofolate]. Arch Biochem Biophys. 1991 May 01; 286(2):633-7.
    View in: PubMed
    Score: 0.004
  12. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci U S A. 1986 Dec; 83(23):8923-5.
    View in: PubMed
    Score: 0.003
  13. Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression. Biochem J. 2005 Nov 01; 391(Pt 3):503-11.
    View in: PubMed
    Score: 0.002
  14. The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis. Biochem Pharmacol. 2003 Mar 01; 65(5):765-71.
    View in: PubMed
    Score: 0.002
  15. Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines. Biochem J. 2002 Nov 01; 367(Pt 3):741-50.
    View in: PubMed
    Score: 0.002
  16. Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034. Clin Cancer Res. 2000 Jul; 6(7):2677-84.
    View in: PubMed
    Score: 0.002
  17. Re: Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo. J Natl Cancer Inst. 1999 Dec 01; 91(23):2047-50.
    View in: PubMed
    Score: 0.002
  18. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. J Biol Chem. 1998 Nov 13; 273(46):30189-98.
    View in: PubMed
    Score: 0.002
  19. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells. Adv Enzyme Regul. 1997; 37:59-76.
    View in: PubMed
    Score: 0.001
  20. Growth of ovarian-carcinoma cell lines at physiological folate concentration: effect on folate-binding protein expression in vitro and in vivo. Int J Cancer. 1995 Nov 03; 63(3):395-401.
    View in: PubMed
    Score: 0.001
  21. Rapid quantitative PCR for determination of relative gene expressions in tissue specimens. PCR Methods Appl. 1995 Apr; 4(5):305-8.
    View in: PubMed
    Score: 0.001
  22. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM. Cancer Res. 1995 Feb 01; 55(3):566-73.
    View in: PubMed
    Score: 0.001
  23. Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia. Blood. 1994 Jul 15; 84(2):564-9.
    View in: PubMed
    Score: 0.001
  24. Altered transport of folic acid and antifolates through the carrier mediated reduced folate transport system in a human leukemia cell line resistant to (6R) 5,10-dideazatetrahydrofolic acid (DDATHF). Adv Exp Med Biol. 1993; 338:775-8.
    View in: PubMed
    Score: 0.001
  25. Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin. Cancer Res. 1991 Feb 01; 51(3):789-93.
    View in: PubMed
    Score: 0.001
  26. The effect of methotrexate on the folate coenzyme pools in human hepatoma cells in culture. Adv Exp Med Biol. 1991; 309A:75-8.
    View in: PubMed
    Score: 0.001
  27. Accumulation of tetrahydrofolates in human plasma after leucovorin administration. Cancer Chemother Pharmacol. 1989; 23(6):353-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.